ZY Drug Delivery Technology Platforms
Drugs have long been used to improve health and extend lives. The practice of drug delivery has changed dramatically in the past few decades and even greater changes are anticipated in the near future. Yet, with all of this progress, many drugs, even those discovered using the most advanced molecular biology strategies, have unacceptable side effects due to the drug / DDS interacting with healthy tissues, which limited treatments for cancer, CNS, and infectious diseases.
ZY Therapeutics interdisciplinary team are focused on developing innovative drug delivery systems (DDS) for the targeted delivery and/or controlled release of therapeutic agents.
Please check our technology platforms below.
Vitamin Modified Polymeric Carbohydrate Drug Encapsulation Nano-delivery Platform
New generation of nano-delivery for optimal combo therapy in tumor treatment. According to Nanotechnology Characterization Lab studies, this type of nanoparticles has a unique drug release property that may result in optimal tissue distribution and synergy to combo therapy.
Biocompatible Human Serum Albumin (HSA) Drug Encapsulation Nano-delivery Process Technology
With ZY innovative process technology, the well established HSA nano-encapsulation became more affordable and easier for manufacturing access. This technology can cut current cost of marketed product as well as provide viable new products.